Capecitabine in adjuvant radiochemotherapy for gastric adenocarcinoma

Publicado en línea: 25 abr 2014

Páginas: 189 - 196

Recibido: 28 jun 2013

Aceptado: 13 ago 2013

DOI: https://doi.org/10.2478/raon-2013-0065

Palabras clave

gastric cancer, capecitabine, adjuvant therapy, radiochemotherapy, survival, toxicity

© by Irena Oblak

This article is distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.